Balancing recurrence risk, side effects and patient preference in the treatment of multiple metachronous testicular tumours can be challenging. We present the case of a young male patient who developed 3 different primary testicular neoplasms over an 8-year period, each associated with retroperitoneal lymphadenopathy requiring chemotherapy. The first tumour at age 19 was managed with radical orchiectomy. Four years later, a partial orchiectomy was performed to remove 2 small lesions. Another 4 years later, a complete orchiectomy was required for an additional tumour. This case highlights the caveats of testis-sparing surgery for testis cancer and the need for careful surveillance in these patients.
Written by:
Forbes CM1, Metcalfe C1, Murray N2, Black PC1 Are you the author?
1Department of Urologic Sciences, University of British Columbia, Vancouver, BC; 2Department of Medical Oncology, Vancouver Cancer Centre, BC Cancer Agency, University of British Columbia, Vancouver, BC.
Reference: Can Urol Assoc J. 2013 Sep;7(9-10):E630-3
doi: 10.5489/cuaj.1260
PubMed Abstract
PMID: 24409211
UroToday.com Testicular Cancer Section
